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ABSTRACT
Objectives: To assess and compare patient perceived
quality of osteoarthritis (OA) management in primary
healthcare in Denmark, Norway, Portugal and the UK.
Methods: Participants consulting with clinical signs
and symptoms of knee OA were identified in 30 general
practices and invited to complete a cross-sectional
survey including quality indicators (QI) for OA care.
A QI was considered as eligible if the participant had
checked ‘Yes’ or ‘No’, and as achieved if the participant
had checked ‘Yes’ to the indicator. The median
percentage (with IQR and range) of eligible QIs
achieved by country was determined and compared in
negative binominal regression analysis. Achievement of
individual QIs by country was determined and
compared using logistic regression analyses.
Results: A total of 354 participants self-reported QI
achievement. The median percentage of eligible QIs
achieved (checked ‘Yes’) was 48% (IQR 28%, 64%;
range 0–100%) for the total sample with relatively
similar medians across three of four countries.
Achievement rates on individual QIs showed a large
variation ranging from 11% (referral to services for
losing weight) to 67% (information about the
importance of exercise) with significant differences in
achievement rates between the countries.
Conclusions: The results indicated a potential for
improvement in OA care in all four countries, but for
somewhat different aspects of OA care. By exploring
these differences and comparing healthcare services,
ideas may be generated on how the quality might be
improved across nations. Larger studies are needed to
confirm and further explore the findings.
INTRODUCTION
Knee osteoarthritis (OA) is a prevalent
chronic joint condition that affects the whole
joint and may cause pain, stiffness and func-
tional disability.1 Owing to the increase in
the ageing population and the epidemic of
obesity, the incidence of OA is increasing.2
OA is one of the leading causes of global dis-
ability3 4 and is expected to be the fourth
leading cause of disability by the year 2020.1
Hence, the burden of OA will become a
major challenge for health systems globally.1
Evidence-based recommendations have the
potential to improve the quality of healthcare
by promoting interventions of proven beneﬁt
and discouraging unnecessary, ineffective or
harmful interventions. International and
national guidelines for OA treatment, includ-
ing those made by the European League
Against Rheumatism (EULAR), American
College of Rheumatology (ACR),
Osteoarthritis Research Society International
(OARSI) and the UK National Institute for
Health and Care Excellence (NICE), have
been available for some time.5–12 The ﬁrst
message that emerges from the guidelines is
that there is a range of simple interventions
for which there is evidence of clinical effect-
iveness. However, clinical practice does not
always reﬂect these recommendations.13 14
Adherence to recommendations for care
may be measured using process quality indi-
cators (QI). A QI can be deﬁned as a “meas-
urable [element] of practice performance
for which there is evidence or consensus that
it can be used to assess the quality, and
Key messages
What is already known on this subject?
▸ Clinical practice does not always reflect guideline
recommendations.
What does this study add?
▸ Patient-reported quality of care shows a large
variation on different quality indicators.
▸ The differences in achievement rates across four
European countries may reflect differences in
healthcare priorities.
How might this impact on clinical practice?
▸ By exploring differences in quality of care and
healthcare services, ideas for improving health-
care may be developed.
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hence change in the quality, of care provided”.15 A
limited number of QI lists for OA care have been devel-
oped.16–23
A small number of previous studies have examined the
quality of OA care using QIs. The results show patient-
reported achievement of OA QIs between 22% and 72%,
suggesting that primary healthcare for older adults with
OA is suboptimal.13 14 20 24–28 Although patient self-
reported QI measures may have some limitations with
regard to accuracy and recall bias, they provide an
important perspective of the quality of OA care and
mirror the care as perceived by the patient. Further,
patient-reported measures can include elements of care
that are less reliably captured from the medical records,
for example, patient information or functional assess-
ments. The patient perspective of OA QI attainment has
so far received limited attention, and differences related
to the QI items and study design make it challenging to
directly compare study results. This EULAR-funded study
is the ﬁrst study that has applied the same set of QI items
in four European countries, which allows a cross-national
comparison of OA QI achievement.
This study aimed to determine the self-reported QI
achievement for OA care among adults with knee OA
and to compare QI achievement cross-nationally
between Denmark, Norway, Portugal and the UK.
METHODS
Study design
This study includes data from cross-sectional surveys in
primary healthcare in four European countries:
Denmark (DK), Norway (NO),29 Portugal (PT) and the
UK (UK).30 Ethical approvals were granted for all four
surveys (see online supplementary ﬁle 1). Research part-
ners have been involved in designing the surveys in the
four countries, and in this study in the design and
writing. This paper is written in concordance with the
STROBE guidelines for reporting observational studies.31
Setting and participant recruitment
In all four surveys, the participants were recruited from
primary healthcare. Adults aged 45 years and over con-
sulting their general practitioner (GP) with a knee OA
diagnosis recorded in the medical records were identiﬁed
between 2012 and 2014. Participants with inﬂammatory
arthritis, malignant illness or an inability to complete the
questionnaire were excluded. There were some minor
differences in eligibility criteria between the four surveys,
and the details are provided in online supplementary ﬁle
1. Written consent was obtained and questionnaires were
completed either immediately after the GP consultation
on site (DK, NO and PT) or at home (DK, NO and UK)
and returned in a prepaid envelope.
The questionnaire
A set of QI items for OA care was included in all four
surveys (see online supplementary ﬁle 2). In three
countries (NO, DK and PT), the OsteoArthritis QI
(OA-QI) questionnaire was used. The OA-QI question-
naire was developed in 2010 using published QIs, an
expert panel and patient interviews.20 Acceptable validity
and moderate test-retest reliability were demonstrated in
a Norwegian OA cohort.20 The OA-QI questionnaire has
been subject to a forward and backward translation pro-
cedure into English and Danish, and then from English
into Portuguese. The OA-QI questionnaire includes
17 items with ‘Yes’, ‘No’ response options and a third
option if the item was not applicable (eg, ‘Not over-
weight’ for items on weight management) or the partici-
pant did not remember. The UK survey applied a
variation of the QI set: the patient-generated MOSAICS
QI questionnaire.30 Fourteen QI items were measured
consistently in all four countries and included in the
main analysis (QIs numbers 4, 9 and 12 from the OA-QI
were not included). Five items addressed patient educa-
tion and information about disease development, treat-
ment alternatives, self-management, weight management
and physical activity. Regular provider assessments are
addressed in two questions. Four questions were related
to pharmacological treatment and three addressed
referrals.
Age, gender and body height and weight were self-
reported or measured (DK), and the body mass index
(BMI) was calculated. Comorbidity was self-reported
(DK, NO and PT) or obtained from a medical record
review for the previous 24 months (UK). Inﬂammatory
arthritis included ankylosing spondylitis, Sjogren’s syn-
drome, psoriasis, psoriatic arthritis, polymyalgia rheuma-
tica, systemic lupus erythematosus and rheumatoid
arthritis. Chronic comorbidity included heart disease,
lung disease, osteoporosis, cancer and diabetes. Knee
function was self-reported in DK, NO and PT using the
Knee injury and Osteoarthritis Outcome Score
(KOOS),32 whereas the Western Ontario and McMaster
Universities Arthritis Index Short Form 8-item (WOMAC
SF-8)33 function scale score was used in the UK. The
WOMAC function scale score can be derived from the
KOOS, so the WOMAC SF-8 function scale score was
calculated for all countries. The eight items include:
descending stairs, ascending stairs, rising from sitting,
walking on a ﬂat surface, getting in/out of a car, shop-
ping, putting on a sock and getting on/off the toilet.
The scale score ranges from 0 to 100, with 0 indicating
no functional problems. The KOOS was not initially
included in the questionnaire in PT and only 30% of
patients from PT had an SF-8 score determined.
Statistical analyses
QIs were considered as achieved if the participant had
checked ‘Yes’ to an indicator. Responses were excluded
(not eligible) from analysis for that QI if there was a
missing/ambiguous response or if the participant had
responded ‘Don’t remember’, ‘Not overweight’, ‘No
such problems’, ‘No pain/discomfort’ or ‘Not severely
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troubled’. Hence, the number of eligible items varied
from participant to participant.
The median (with IQR and range) number of eligible
QIs (ie, checked ‘Yes’ or ‘No’) and the median (IQR,
range) percentage of eligible QIs achieved in each
country were determined on the basis of the 14 QIs
measured in all 4 countries. Further, the percentage of
people having all eligible QIs achieved (checked solely
‘Yes’), and the percentage with no eligible QIs achieved
(checked solely ‘No’) was determined. Differences in
the number of QIs achieved between countries, using
the number of eligible QIs for each person as the expos-
ure variable, were determined using negative binomial
regression, ﬁrst unadjusted and then adjusted for age,
gender, BMI and comorbidity. Results are reported as
rate ratios (RR) and 95% CI using NO as the reference
country. In sensitivity analyses, we repeated the analysis
only in people from NO, DK and the UK for whom a
WOMAC function scale score was available, and further
adjusted for functional limitation; and then restricted
the analysis to those without inﬂammatory arthritis
comorbidity.
Achievement of each QI was compared between coun-
tries using logistic regression, again unadjusted and then
adjusted for age, gender, BMI and comorbidity.
Analysis was performed using Stata/MP 13.1 for
Windows.
RESULTS
Participants
In total, 354 patients were included in the analyses
(ﬁgure 1). The mean age was 67.7 years (SD 10.1), the
proportion of females was 67%, and the mean BMI was
28.5 kg/m2 (SD=4.8; table 1). The WOMAC SF-8 func-
tion scale score showed better function among the sub-
sample of the Portuguese participants and Danish
participants compared with the Norwegian and UK
participants. The presence of inﬂammatory arthritis was
highest in the Danish cohort compared with the other
cohorts, and the presence of a chronic disease was
higher in the Danish and Portuguese cohorts. The UK
had the lowest comorbidity levels, but this was based
entirely on medical records rather than self-report.
Number of QIs achieved in the total sample and by country
The study participants considered most of the 14 QIs to
be relevant (eg, checked ‘Yes’ or ‘No’), and the median
number of eligible QIs was 12 (IQR=10–14, range 0–14).
The median percentage of eligible QIs achieved
(checked ‘Yes’) was 48% (IQR=28%, 64%; range
0–100%). For 5% of the total sample, none of the QIs
were achieved, and for 2% all eligible QIs were achieved.
The median percentage of QIs achieved by country
was relatively similar across three of the countries, but
signiﬁcantly lower in DK (23%; unadjusted RR com-
pared to NO=0.54; 95% CI 0.43 to 0.68; table 2). DK still
had a signiﬁcantly lower level of achievement after
adjustment for age, gender, BMI and comorbidity
(RR=0.49; 0.39, 0.62), when further adjusted for the
WOMAC function scale score (RR=0.47; 0.38, 0.59), and
when restricted to those without inﬂammatory arthritis
comorbidity (RR=0.47; 0.34, 0.66). None of the covari-
ates were associated with the number of QIs achieved in
the ﬁnal models.
Achievement of individual QIs in the total sample
Achievement of individual QIs ranged from 11% to 67%
(table 3). QIs with the lowest percentage achievement
were related to referral to services for losing weight
(11%), functional assessments (appliances and aids
13%; walking aids 31%), consideration of corticosteroid
joint injections (25%) and referral for evaluation for
surgery (36%). QIs with the highest percentage achieve-
ment were around delivery of information about the
Figure 1 Flow diagram.
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importance of exercise (67%), information about their
joint problem (55%), information about OA treatment
(55%), information about anti-inﬂammatory (side)
effects (59%), and the recommendation of paracetamol
as ﬁrst-line medication (59%).
Achievement of individual QIs by country
Among the four countries, the UK study showed the
highest achievement rates for the information QIs
around the joint problem, treatment, and managing
OA, and for stronger medication and joint injection QIs
(table 4). The Norwegian study had the highest achieve-
ment rates for exercise information, referral for physical
activity and recommendation of paracetamol. The
Portuguese study showed the highest achievement rates
for advice to lose weight and referral to services for
losing weight. DK had the lowest percentage achieve-
ment for 13 of the 14 QIs measured in all four
countries.
DISCUSSION
This study aimed to determine patient self-reported QI
achievement for OA care among adults with knee OA
and compare QI achievement across four European
countries. The percentage of participants in the total
sample who achieved the individual QIs varied widely
across QIs, and the number of QIs achieved by patients
revealed some differences between the countries. There
were similarities and differences between the countries
in relation to achievement of the individual QIs.
QIs achieved in the total sample and by country
In contrast to two previous studies, which showed that
age, gender, education and severity of the OA disease
were related to QI achievement,13 14 patient character-
istics in the present study were not associated with QI
achievement. The median percentage of QIs achieved
for the total study sample was similar to the rates in two
previous studies of patient-reported OA QI achievement
rates in primary healthcare,24 27 34 higher median than
in three studies14 20 28 and lower median than in one
study.26 It has previously been shown that adherence to
QIs in OA care was lower compared to that in gout or
other chronic conditions in older adults.25 28 35
According to Grol,36 achievement rates of approximately
60–70% have been demonstrated for most chronic dis-
eases, which is higher than the rates in this study.
Table 1 Characteristics of participants
Norway Denmark Portugal UK Total
Number of responders 71 49 135 99 354
Age, mean (SD) 66.1 (10.18) 57.6 (7.55) 69.2 (8.15) 71.7 (10.07) 67.7 (10.07)
Female, n (%) 48 (68) 26 (53) 104 (77) 59 (60) 237 (67)
BMI, mean (SD) 28.4 (4.22) 27.3 (2.58) 29.5 (5.23) 28.0 (5.20) 28.5 (4.78)
WOMAC SF-8,* mean (SD) 46.4 (19.17) 31.6 (15.65) 28.7 (22.53)† 45.8 (19.58) 40.4 (20.65)
Inflammatory arthritis,‡ n (%) 19 (31) 29 (59) 56 (42) 4 (4) 108 (31)
Chronic disease,§ n (%) 32 (46) 31 (63) 98 (73) 34 (34) 195 (55)
*Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Short Form 8-item function scale score (0–100, 0=best).
†n=41.
‡Inflammatory arthritis, ankylosing spondylitis, Sjogren’s syndrome, psoriasis, psoriatic arthritis, polymyalgia rheumatica, systemic lupus
erythematosus and rheumatoid arthritis.
§Chronic disease: heart disease, lung disease, other musculoskeletal disorder, cancer and diabetes.
BMI, body mass index.
Table 2 Number of quality indicators (QI) achieved by country*
Norway,
n=71 Denmark, n=49 Portugal, n=135 UK, n=99
Total,
n=354
Number of eligible QIs, median (IQR) 11 (9, 13) 12 (10, 14) 12 (10, 14) 13 (11, 14) 12 (10, 14)
Number of eligible QIs, range 6, 14 0, 14 0, 14 3, 14 0, 14
No eligible QIs achieved, % (95% CI) 0 (0 to 5) 8 (3 to 20) 10 (6 to 16) 2 (1 to 7) 5 (3 to 8)
All eligible QIs achieved, % (95% CI) 4 (1 to 12) 2 (0 to 11) 1 (0 to 5) 1 (0 to 6) 2 (1 to 4)
Eligible QIs achieved, median % (IQR) 50 (33, 63) 23 (10, 41) 48 (25, 67) 55 (36, 67) 48 (28, 64)
Eligible QIs achieved, range % 7, 100 0, 100 0, 100 0, 100 0, 100
Unadjusted rate ratio for number of eligible
QIs achieved (95% CI)
1.00 0.54 (0.43 to 0.68) 0.92 (0.79 to 1.08) 1.06 (0.90 to 1.25)
Adjusted† rate ratio for number of eligible
QIs achieved (95% CI)
1.00 0.49 (0.39 to 0.62) 0.92 (0.77 to 1.09) 1.10 (0.92 to 1.31)
*Of the 14 QIs measured in all four countries.
†Adjusted for age, gender, body mass index and comorbidity.
Eligible QIs excludes those stating not applicable/do not remember and those not responding to the QI.
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Although the median percentage of QIs achieved was
relatively similar for three of the countries, the median
for the Danish cohort in this study was signiﬁcantly
lower even after adjustments for patient characteristics.
Although a real difference cannot be ruled out, it might
be due to a selection bias as the Danish data were
extracted from baseline data among a small number of
participants recruited to a randomised controlled trial
of pharmacological versus exercise treatment.
Achievement of individual QIs in the total sample
and by country
There was substantial variation in the achievement of
individual QIs across the countries. Differences in
healthcare systems (ie, access to dieticians, physiothera-
pists, occupational therapists and orthopaedic surgeons;
or the healthcare economy and patient payment) may
explain a substantial proportion of the variation in indi-
vidual QI achievement rates seen in this study. The
observed variation could also be related to differences in
patient expectations or attitudes towards OA, and in
knowledge about OA and recommended treatment.
There may also be variation in the timing of when
people choose to consult a healthcare professional for
their OA symptoms. Hence, the patients’ disease severity
and burden of disease may vary at the time of
consultation.
The UK data showed the highest achievement rates
among the four countries regarding information about
the joint problem, treatment alternatives and self-
management as compared to the other three countries.
Compared to two previous UK studies,13 28 the achieve-
ment rates in this study were substantially greater (76%
vs 30/18%). This may have been related to the recruit-
ment procedures in the MOSAICS study where eligible
participants were identiﬁed via electronic pop-up
screens in general practices, which could have reminded
GPs about treatment recommendations for OA and led
to higher achievement rates.
The total study sample showed substantially higher
achievement rates for advice to exercise compared to a
Canadian study (69% vs 25%),14 and much higher refer-
ral rates to supervised exercise (physical therapy) com-
pared to a recent Australian study (52% vs 4%).37 The
Norwegian cohort had the highest achievement rates
regarding advice to exercise and referrals to supervised
exercise. Whether this is due to differences in the
healthcare system and organisation, gross domestic
product and healthcare economy, national health
authority strategies, or due to differences in GPs’ knowl-
edge or attitude towards exercises and physical therapy
could not be investigated in this study.
In the total study sample, the low rate for referrals to
services (ie, dieticians) for support on losing weight is in
line with the results in a recent Australian study.37
However, the low rates are in contrast to the evidence
showing that obesity is a risk factor for OA progression
and that even modest weight reductions may reduce
symptoms.38 A UK survey showed that BMI monitoring
and adherence to exercise were less frequently moni-
tored by GPs as compared to pain, function and anal-
gesia. The authors suggest that lack of time, lack
of conﬁdence in providing advice and effectiveness of
interventions, lack of reimbursements, and lack
of patient adherence and motivation represent major
barriers to GPs discussing lifestyle interventions (eg,
exercise and losing weight) with their patients.39 In this
study, the Portuguese cohort had the highest achieve-
ment rate for advice on losing weight. Although the
Portuguese GPs’ referral rate to weight loss services was
only 21%, this was much higher compared to the
achievement rates in the other three countries. This
ﬁnding most likely reﬂects a priority in the Portuguese
healthcare services since most healthcare centres in the
region of Algarve have been staffed with a dietician or
Table 3 Achievement of individual quality indicators (QI) for the total study sample*
Indicator
Number of people
eligible†
Number of people
achieved
Achievement
rate, % (95% CI)
Information about joint problem 319 176 55 (50 to 61)
Information about treatment 331 181 55 (49 to 60)
Advice on managing/living with osteoarthritis 323 157 49 (43 to 54)
Information about exercise 330 221 67 (62 to 72)
Referred for physical activity 325 158 49 (43 to 54)
Advised to lose weight 247 114 46 (40 to 52)
Referred to services for losing weight 247 27 11 (8 to 15)
Assessed for walking aid 214 67 31 (25 to 38)
Assessed for daily living appliances and aids 183 23 13 (9 to 18)
Recommended paracetamol 340 202 59 (54 to 64)
Offered stronger painkillers 322 167 52 (46 to 57)
Information about anti-inflammatory medicine (side) effects 311 183 59 (53 to 64)
Considered joint injection 329 81 25 (20 to 30)
Referred for evaluation of surgery 262 94 36 (30 to 42)
*Including only the 14 QIs measured in all four countries.
†Eligible excludes those stating not applicable/do not remember and those not responding to the QI.
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Table 4 Individual quality indicator achievement by country
Norway
Total n=71
Denmark
Total n=49
Portugal
Total n=135
UK
Total n=99
Indicator
Eligible
n*
Achieved
n (%)
Eligible
n*
Achieved
n (%)
Eligible
n*
Achieved
n (%)
Eligible
n*
Achieved
n (%)
Information about joint problem 62 36 (58) 42 10 (24)† 121 59 (49) 94 71 (76)‡
Information about treatment 63 32 (51) 47 18 (38)† 127 59 (46) 94 72 (77)‡
Advice on managing/living with OA 60 26 (43) 44 7 (16)† 127 56 (44) 92 68 (74)‡
Information about changing lifestyle§ 55 18 (33) 47 8 (17)† 127 56 (44)
Information about exercise 63 52 (83) 47 25 (53)† 129 84 (65) 91 60 (66)
Referred for physical activity 67 53 (79) 47 10 (21)† 124 53 (43)† 87 42 (48)†
Advised to lose weight 42 17 (40) 33 8 (24)† 98 59 (60) 74 30 (41)
Referred to services for losing weight 38 4 (11) 35 0 (0)† 97 19 (20) 77 4 (5)
Assessment of problems in daily activities§ 48 22 (46) 38 14 (37) 93 36 (39)†
Assessed for walking aid 42 11 (26) 28 0 (0)† 69 27 (39) 75 29 (39)
Assessed for daily living appliances/aids 33 6 (18) 29 0 (0)† 68 11 (16) 53 6 (11)
Assessment of pain§ 66 48 (73) 47 22 (47)† 126 74 (59)†
Recommended paracetamol 66 48 (73) 48 29 (60) 129 67 (52)† 97 58 (60)
Offered stronger painkillers 61 27 (44) 47 17 (36) 122 62 (51) 92 61 (66)‡
Information about anti-inflammatory medicine (side) effects 60 36 (60) 45 19 (42)† 119 79 (66) 87 49 (56)
Considered joint injection 68 11 (16) 44 3 (7) 126 32 (25) 91 35 (38)‡
Referred for surgery 54 23 (43) 33 5 (15)† 101 39 (39) 74 27 (36)
*Excluding missing, not applicable, do not remember.
†Lower achievement than in Norway (p<0.05), adjusting for age, gender, body mass index (BMI) (except for items relating to weight), comorbidity.
‡Better achievement than in Norway (p<0.05), adjusting for age, gender, BMI (except for items relating to weight), comorbidity.
§Not measured in the UK.
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nutritionist, which is in contrast to that in the other
three countries.
Apart from QIs related to weight, the QIs for func-
tional assessments, corticosteroid injections and referrals
for surgery represented the lowest achievement rates in
this study. This could reﬂect a lower priority among
health professionals for these aspects of OA care or
limited access to or availability of such assessments and
treatment. The UK and Portuguese cohorts had (non-
signiﬁcantly) higher achievement rates for assessment
for walking aids, whereas the Norwegian cohort had the
highest rates for daily living appliances/aids. There was
a higher achievement rate for recommendation of para-
cetamol in the Norwegian cohort, and of stronger pain-
killers in the UK cohort. This may reﬂect differences in
national pharmacological guidelines or differences in
the medical practice between the countries.
Strengths and limitations
The application of the same set of QIs across primary
healthcare in the same time period and in similar set-
tings in four different European countries allowed for
cross-national comparisons and represents a major
strength of this study. However, there were some minor
differences in the phrasing of the UK QI items com-
pared to the QIs in the other three countries, which
may possibly have inﬂuenced the patient-reported
achievement. Some GPs may have been aware of the
items in the questionnaire. If they changed their behav-
iour due to this, it may have resulted in somewhat
higher achievement rates. The populations in the four
countries might have been somewhat different due to
differences in the inclusion criteria and the target popu-
lation, which may have inﬂuenced the characteristics of
participants and the achievement rates. Comorbidity was
self-reported in most countries, but extracted from
medical records in the UK, so this may have induced
some differences between the study populations.
However, none of these variables were associated with
the number of QIs achieved in the ﬁnal models. The
unknown number of people screened in three countries
and the somewhat limited number of participants
recruited in each country implies that some caution
should be applied in generalising the study results to the
general populations in the four countries. However, the
results from the Norwegian cohort were similar to the
results from a recent nationwide survey, which
strengthen the generalisability. It is also a limitation that
we had no data on psychological distress or depression,
expectations, knowledge on OA treatment and health-
care utilisation and that we were not able to adjust ana-
lyses for the differences in healthcare systems and access
to OA care across the countries.
Implications
Quality improvement initiatives targeting OA care are
becoming increasingly important as the prevalence of
OA is expected to further increase, and implementation
of evidence-based OA treatment is likely to reduce the
associated burden of disability.9–12 Carefully designed QIs
have the potential to quantify and address gaps in clinical
care,40 and can improve delivery of provided care
through an appropriate measurement of healthcare
system performance across providers, system levels and
regions.41 This study represents a novel attempt to imple-
ment the same set of QIs and compare QI achievement
rates across populations from four different countries.
Adherence to process QIs in rheumatology has recently
been shown to be associated with improved patients’ out-
comes,42 and a recent study demonstrated that by imple-
menting core recommendations for OA treatment, the
need for total joint replacements may be postponed.43
Hence, health professionals should aim for higher adher-
ence to standards of care and guideline recommenda-
tions. However, multifaceted approaches, including
system-level interventions and patient-focused interven-
tions among others, may be needed to improve the
quality of OA care.44 Joint initiatives and cross-country
collaborations to improve OA care and implementation
of international guidelines could be explored as one of
several potential ways to meet this healthcare challenge.
In conclusion, the results of this study indicate that
there exists a potential for improvement in OA care in
all four countries, but for somewhat different aspects of
OA care. QIs may be used to assess and monitor the
quality of OA care, and larger studies with more coun-
tries and larger sample sizes may allow for further
explorations of differences in QI achievement between
countries. By exploring such differences and comparing
healthcare services across countries, ideas may be gener-
ated on how the quality of OA care might be improved
internationally.
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